Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Mormino

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Neuropsychology Review|August 11, 2014
The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsElizabeth C Mormino
Brain : a Journal of Neurology|May 8, 2023
The pathotome and precision healthKyan Younes, Elizabeth C Mormino
Brain : a Journal of Neurology|April 28, 2018
Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials?Oskar Hansson, Elizabeth C Mormino
Neurology|July 5, 2013
Cognitively stimulating activities to keep dementia at bayPrashanthi Vemuri, Elizabeth C Mormino
JAMA Neurology|April 12, 2016
Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention TrialsElizabeth C Mormino, Kathryn V Papp
JAMA Neurology|August 14, 2023
Tau Pathology Without Aβ-A Limited PART of Clinical ProgressionSusan M Landau, Elizabeth C Mormino
Neurology|May 21, 2010
A BOLD move: clinical application of fMRI in agingAnsgar J Furst, Elizabeth C Mormino
JAMA Neurology|July 18, 2018
A New Tool for Clinical Neuroscience-Synaptic ImagingElizabeth C Mormino, William J Jagust
Neurology|August 11, 2017
<i>APOE</i> genotype and early β-amyloid accumulation in older adults without dementiaYen Ying Lim, Elizabeth C Mormino,
JAMA Neurology|January 31, 2022
Prevalence Rates of Amyloid Positivity-Updates and RelevanceChristina B Young, Elizabeth C Mormino
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Neuropsychology Review|August 11, 2014
The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsElizabeth C Mormino
Brain : a Journal of Neurology|May 8, 2023
The pathotome and precision healthKyan Younes, Elizabeth C Mormino
Brain : a Journal of Neurology|April 28, 2018
Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials?Oskar Hansson, Elizabeth C Mormino
Neurology|July 5, 2013
Cognitively stimulating activities to keep dementia at bayPrashanthi Vemuri, Elizabeth C Mormino
JAMA Neurology|April 12, 2016
Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention TrialsElizabeth C Mormino, Kathryn V Papp
JAMA Neurology|August 14, 2023
Tau Pathology Without Aβ-A Limited PART of Clinical ProgressionSusan M Landau, Elizabeth C Mormino
Neurology|May 21, 2010
A BOLD move: clinical application of fMRI in agingAnsgar J Furst, Elizabeth C Mormino
JAMA Neurology|July 18, 2018
A New Tool for Clinical Neuroscience-Synaptic ImagingElizabeth C Mormino, William J Jagust
Neurology|August 11, 2017
<i>APOE</i> genotype and early β-amyloid accumulation in older adults without dementiaYen Ying Lim, Elizabeth C Mormino,
JAMA Neurology|January 31, 2022
Prevalence Rates of Amyloid Positivity-Updates and RelevanceChristina B Young, Elizabeth C Mormino
Pageof 18